Year |
Citation |
Score |
2019 |
Iannotti MJ, MacArthur R, Jones R, Tao D, Singeç I, Michael S, Inglese J. Detecting Secretory Proteins by Acoustic Droplet Ejection in Multiplexed High-Throughput Applications. Acs Chemical Biology. PMID 30699290 DOI: 10.1021/Acschembio.9B00001 |
0.375 |
|
2017 |
Stark AL, Madian AG, Williams SW, Chen V, Wing C, Hause RJ, To LA, Gill AL, Myers JL, Gorsic LK, Ciaccio MF, White KP, Jones RB, Dolan ME. Identification of novel protein expression changes following cisplatin treatment and application to combination therapy. Journal of Proteome Research. PMID 28902521 DOI: 10.1021/Acs.Jproteome.7B00576 |
0.763 |
|
2017 |
Ciaccio MF, Jones RB. Microwestern Arrays for Systems-Level Analysis of SH2 Domain-Containing Proteins. Methods in Molecular Biology (Clifton, N.J.). 1555: 453-473. PMID 28092050 DOI: 10.1007/978-1-4939-6762-9_27 |
0.787 |
|
2015 |
Ciaccio MF, Chen VC, Jones RB, Bagheri N. The DIONESUS algorithm provides scalable and accurate reconstruction of dynamic phosphoproteomic networks to reveal new drug targets. Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 776-91. PMID 26057728 DOI: 10.1039/C5Ib00065C |
0.797 |
|
2014 |
Hause RJ, Stark AL, Antao NN, Gorsic LK, Chung SH, Brown CD, Wong SS, Gill DF, Myers JL, To LA, White KP, Dolan ME, Jones RB. Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels. American Journal of Human Genetics. 95: 194-208. PMID 25087611 DOI: 10.1016/J.Ajhg.2014.07.005 |
0.656 |
|
2014 |
Leung KK, Hause RJ, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Molecular & Cellular Proteomics : McP. 13: 1705-23. PMID 24728074 DOI: 10.1074/Mcp.M113.034876 |
0.74 |
|
2014 |
Stark AL, Hause RJ, Gorsic LK, Antao NN, Wong SS, Chung SH, Gill DF, Im HK, Myers JL, White KP, Jones RB, Dolan ME. Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy. Plos Genetics. 10: e1004192. PMID 24699359 DOI: 10.1371/Journal.Pgen.1004192 |
0.67 |
|
2013 |
Somm E, Bonnet N, Zizzari P, Tolle V, Toulotte A, Jones R, Epelbaum J, Martinez A, Hüppi PS, Aubert ML. Comparative inhibition of the GH/IGF-I axis obtained with either the targeted secretion inhibitor SXN101959 or the somatostatin analog octreotide in growing male rats. Endocrinology. 154: 4237-48. PMID 24029240 DOI: 10.1210/En.2013-1427 |
0.311 |
|
2013 |
Lin CY, Huo C, Kuo LK, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, et al. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. Plos One. 8: e65734. PMID 23785446 DOI: 10.1371/journal.pone.0065734 |
0.578 |
|
2013 |
Jones RB. Do low-affinity ErbB receptor protein interactions represent the base of a cell signaling iceberg? Expert Review of Proteomics. 10: 115-8. PMID 23573776 DOI: 10.1586/Epr.12.78 |
0.437 |
|
2012 |
Hause RJ, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. Plos One. 7: e44471. PMID 22973453 DOI: 10.1371/Journal.Pone.0044471 |
0.74 |
|
2012 |
Somm E, Bonnet N, Martinez A, Marks PM, Cadd VA, Elliott M, Toulotte A, Ferrari SL, Rizzoli R, Hüppi PS, Harper E, Melmed S, Jones R, Aubert ML. A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis. The Journal of Clinical Investigation. 122: 3295-306. PMID 22850878 DOI: 10.1172/Jci63232 |
0.357 |
|
2012 |
Madian AG, Wheeler HE, Jones RB, Dolan ME. Relating human genetic variation to variation in drug responses. Trends in Genetics : Tig. 28: 487-95. PMID 22840197 DOI: 10.1016/J.Tig.2012.06.008 |
0.616 |
|
2012 |
Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prevention Research (Philadelphia, Pa.). 5: 788-97. PMID 22562408 DOI: 10.1158/1940-6207.Capr-12-0004-T |
0.761 |
|
2012 |
Stark AL, Hause RJ, Gorsic LK, Antao NN, Chung SH, Gill DF, White KP, Jones RB, Dolan ME. Abstract 1880: Incorporating protein levels with genetic variation and gene expression in sensitivity to chemotherapy Cancer Research. 72: 1880-1880. DOI: 10.1158/1538-7445.Am2012-1880 |
0.662 |
|
2011 |
Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M, Ciaccio MF, Gat-Viks I, Tonti E, DeGrace MM, Clauser KR, Garber M, Eisenhaure TM, Yosef N, Robinson J, Sutton A, ... ... Jones RB, et al. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell. 147: 853-67. PMID 22078882 DOI: 10.1016/J.Cell.2011.10.022 |
0.767 |
|
2011 |
Hause RJ, Kim HD, Leung KK, Jones RB. Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approaches. Expert Review of Proteomics. 8: 565-75. PMID 21999828 DOI: 10.1586/Epr.11.49 |
0.726 |
|
2011 |
Liu J, Kuo WL, Seiwert TY, Lingen M, Ciaccio MF, Jones RB, Rosner MR, Cohen EE. Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin. Head & Neck. 33: 1774-82. PMID 21438065 DOI: 10.1002/Hed.21701 |
0.776 |
|
2011 |
Reka AK, Chen G, Jones R, Kim S, Michailidis G, Kuick R, Pisano M, Beer D, Omenn G, Keshamouni V. Abstract LB-52: Integrative protein and transcriptomic analysis identified an EMT-associated secretory phenotype that correlates with metastasis and predicts survival in lung adenocarcinoma patients Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-52 |
0.371 |
|
2010 |
Liu BA, Jablonowski K, Shah EE, Engelmann BW, Jones RB, Nash PD. SH2 domains recognize contextual peptide sequence information to determine selectivity. Molecular & Cellular Proteomics : McP. 9: 2391-404. PMID 20627867 DOI: 10.1074/Mcp.M110.001586 |
0.416 |
|
2010 |
Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett KL, Barkinge J, Jones RB, Koide A, Superti-Furga G, Koide S. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nature Structural & Molecular Biology. 17: 519-27. PMID 20357770 DOI: 10.1038/Nsmb.1793 |
0.798 |
|
2010 |
Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nature Methods. 7: 148-55. PMID 20101245 DOI: 10.1038/Nmeth.1418 |
0.79 |
|
2009 |
Netzer N, Goodenbour JM, David A, Dittmar KA, Jones RB, Schneider JR, Boone D, Eves EM, Rosner MR, Gibbs JS, Embry A, Dolan B, Das S, Hickman HD, Berglund P, et al. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature. 462: 522-6. PMID 19940929 DOI: 10.1038/Nature08576 |
0.339 |
|
2008 |
Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Molecular Cancer Research : McR. 6: 885-91. PMID 18567793 DOI: 10.1158/1541-7786.Mcr-07-0369 |
0.735 |
|
2006 |
Newman EA, Muh SJ, Hovhannisyan RH, Warzecha CC, Jones RB, McKeehan WL, Carstens RP. Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays. Rna (New York, N.Y.). 12: 1129-41. PMID 16603716 DOI: 10.1261/Rna.34906 |
0.51 |
|
2006 |
Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 439: 168-74. PMID 16273093 DOI: 10.1038/Nature04177 |
0.796 |
|
2004 |
Luo Y, Cho HH, Jones RB, Jin C, McKeehan WL. Improved production of recombinant fibroblast growth factor 7 (FGF7/KGF) from bacteria in high magnesium chloride. Protein Expression and Purification. 33: 326-31. PMID 14711521 DOI: 10.1016/J.Pep.2003.10.013 |
0.462 |
|
2001 |
Ye S, Luo Y, Lu W, Jones RB, Linhardt RJ, Capila I, Toida T, Kan M, Pelletier H, McKeehan WL. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry. 40: 14429-39. PMID 11724555 DOI: 10.1021/Bi011000U |
0.498 |
|
2001 |
Jones RB, Carstens RP, Luo Y, McKeehan WL. 5'- and 3'-terminal nucleotides in the FGFR2 ISAR splicing element core have overlapping roles in exon IIIb activation and exon IIIc repression. Nucleic Acids Research. 29: 3557-65. PMID 11522825 DOI: 10.1093/Nar/29.17.3557 |
0.479 |
|
2001 |
Jones RB, Wang F, Luo Y, Yu C, Jin C, Suzuki T, Kan M, McKeehan WL. The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs. The Journal of Biological Chemistry. 276: 4158-67. PMID 11042206 DOI: 10.1074/Jbc.M006151200 |
0.46 |
|
2000 |
Yu C, Wang F, Kan M, Jin C, Jones RB, Weinstein M, Deng CX, McKeehan WL. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. The Journal of Biological Chemistry. 275: 15482-9. PMID 10809780 DOI: 10.1074/Jbc.275.20.15482 |
0.571 |
|
1998 |
Luo Y, Lu W, Mohamedali KA, Jang JH, Jones RB, Gabriel JL, Kan M, McKeehan WL. The glycine box: a determinant of specificity for fibroblast growth factor. Biochemistry. 37: 16506-15. PMID 9843417 DOI: 10.1021/Bi9816599 |
0.482 |
|
1979 |
Martin T, Jones R, Billings P. HnRNP core proteins: synthesis, turnover and intracellular distribution. Molecular Biology Reports. 5: 37-42. PMID 111032 DOI: 10.1007/Bf00777486 |
0.359 |
|
Show low-probability matches. |